Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
This intro outlines the main advantages of a total return index, emphasizing how it reflects real returns for portfolios that reinvest dividends.
24,528 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
In a bold move amid 13F season, investor Gavin Baker places a major levered bet on Nvidia through call options, signa...
AI data centers are expanding fast, backed by major cloud players. This article dives into why hyperscalers plan spen...
A tech fund placed a sizable bet on a fresh AI chip IPO, wagering roughly $5.8 million. The stock climbed almost 200%...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
A star-studded wedding weekend sparked more than cheers—it raised questions about money, privacy, and branding. This ...
A high profile roast goes viral and reveals more than punchlines. This article uses the michael mocks white writers m...
Feeling like you need to restart your real estate journey? This guide lays out a loan-focused reboot plan: finance op...
Investors woke up to news that rocket stock dropped today, sending shares of Rocket Lab into the spotlight. This arti...
A fresh rally in fintech names has traders watching carefully. This article explores why fiserv stock just popped, wh...
When a founder makes a bold move after a price drop, investors sit up and take notice. This article unpacks what a pu...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...